File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1365-2044.2008.05652.x
- Scopus: eid_2-s2.0-58149263476
- PMID: 19032297
- WOS: WOS:000261444000005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A study to assess the value of bispectral analysis in intravenous sedation with midazolam during third molar surgery under local anaesthesia
Title | A study to assess the value of bispectral analysis in intravenous sedation with midazolam during third molar surgery under local anaesthesia | ||||
---|---|---|---|---|---|
Authors | |||||
Issue Date | 2008 | ||||
Publisher | Wiley-Blackwell Publishing Ltd. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2044 | ||||
Citation | Anaesthesia, 2008, v. 63 n. 12, p. 1302-1308 How to Cite? | ||||
Abstract | This study aimed to determine whether bispectral index (BIS) can be used as an indicator of sedation and recovery with intravenous midazolam. In Part A, 30 healthy patients undergoing third molar extraction under local anaesthesia were recruited. They were sedated with intravenous midazolam titrated to clinical endpoints. BIS values were recorded when adequately sedated (BISS) and when clinical recovery criteria were met (BISR). In Part B, another 30 patients were sedated to the range of BISS obtained in Part A. Recovery was assessed postoperatively when the range of BISR from Part A was reached. BIS titrated patients required less midazolam (p < 0.001). Seventy percent of Part B patients required increments of midazolam during surgery, compared to 16.7% in Part A (p < 0.001). Total dose of midazolam given was lower in Part B (p = 0.025). BIS is not effective as a sole indicator of endpoint in sedation with intravenous midazolam. © 2008 The Association of Anaesthetists of Great Britain and Ireland. | ||||
Persistent Identifier | http://hdl.handle.net/10722/147262 | ||||
ISSN | 2023 Impact Factor: 7.5 2023 SCImago Journal Rankings: 2.400 | ||||
ISI Accession Number ID |
Funding Information: We would like to thank Dr Chandra Rodrigo for his contribution to this study. This study was supported in part by the University of Hong Kong CRCG Small Project Fund (10204354). | ||||
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheung, CW | en_US |
dc.contributor.author | Irwin, MG | en_US |
dc.contributor.author | Chiu, WK | en_US |
dc.contributor.author | Ying, CLA | en_US |
dc.date.accessioned | 2012-05-29T06:01:06Z | - |
dc.date.available | 2012-05-29T06:01:06Z | - |
dc.date.issued | 2008 | en_US |
dc.identifier.citation | Anaesthesia, 2008, v. 63 n. 12, p. 1302-1308 | en_US |
dc.identifier.issn | 0003-2409 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/147262 | - |
dc.description.abstract | This study aimed to determine whether bispectral index (BIS) can be used as an indicator of sedation and recovery with intravenous midazolam. In Part A, 30 healthy patients undergoing third molar extraction under local anaesthesia were recruited. They were sedated with intravenous midazolam titrated to clinical endpoints. BIS values were recorded when adequately sedated (BISS) and when clinical recovery criteria were met (BISR). In Part B, another 30 patients were sedated to the range of BISS obtained in Part A. Recovery was assessed postoperatively when the range of BISR from Part A was reached. BIS titrated patients required less midazolam (p < 0.001). Seventy percent of Part B patients required increments of midazolam during surgery, compared to 16.7% in Part A (p < 0.001). Total dose of midazolam given was lower in Part B (p = 0.025). BIS is not effective as a sole indicator of endpoint in sedation with intravenous midazolam. © 2008 The Association of Anaesthetists of Great Britain and Ireland. | en_US |
dc.language | eng | en_US |
dc.publisher | Wiley-Blackwell Publishing Ltd. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2044 | en_US |
dc.relation.ispartof | Anaesthesia | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Anesthesia Recovery Period | en_US |
dc.subject.mesh | Anesthesia, Dental - Methods | en_US |
dc.subject.mesh | Anesthesia, Local | en_US |
dc.subject.mesh | Conscious Sedation - Methods | en_US |
dc.subject.mesh | Drug Administration Schedule | en_US |
dc.subject.mesh | Electroencephalography - Drug Effects | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hypnotics And Sedatives - Administration & Dosage - Pharmacology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mental Recall - Drug Effects | en_US |
dc.subject.mesh | Midazolam - Administration & Dosage - Pharmacology | en_US |
dc.subject.mesh | Molar, Third - Surgery | en_US |
dc.subject.mesh | Monitoring, Intraoperative - Methods | en_US |
dc.subject.mesh | Tooth Extraction | en_US |
dc.subject.mesh | Young Adult | en_US |
dc.title | A study to assess the value of bispectral analysis in intravenous sedation with midazolam during third molar surgery under local anaesthesia | en_US |
dc.type | Article | en_US |
dc.identifier.email | Cheung, CW:cheucw@hku.hk | en_US |
dc.identifier.email | Irwin, MG:mgirwin@hku.hk | en_US |
dc.identifier.authority | Cheung, CW=rp00244 | en_US |
dc.identifier.authority | Irwin, MG=rp00390 | en_US |
dc.description.nature | link_to_OA_fulltext | en_US |
dc.identifier.doi | 10.1111/j.1365-2044.2008.05652.x | en_US |
dc.identifier.pmid | 19032297 | - |
dc.identifier.scopus | eid_2-s2.0-58149263476 | en_US |
dc.identifier.hkuros | 160827 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-58149263476&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 63 | en_US |
dc.identifier.issue | 12 | en_US |
dc.identifier.spage | 1302 | en_US |
dc.identifier.epage | 1308 | en_US |
dc.identifier.isi | WOS:000261444000005 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.citeulike | 3502051 | - |
dc.identifier.issnl | 0003-2409 | - |